U.S. Markets closed

SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of Aratana Therapeutics, Inc – PETX

BALA CYNWYD, PA / ACCESSWIRE / May 6, 2019 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Aratana Therapeutics, Inc (''Aratana'' or ''the Company'') (PETX) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Elanco Animal Health. (''Elanco'').

Click here to learn http://www.brodskysmith.com/cases/aratana-therapeutics-inc-nasdaq-petx/, or call: 877-534-2590. There is no cost or obligation to you.

Under the terms of the transaction, Aratana shareholders will receive only 0.1481 of a share of Elanco stock for each share of Aratana stock they own. The transaction values Aratana at only approximately $4.75 per share. The investigation concerns whether the Board of Aratana breached their fiduciary duties to shareholders and whether Elanco is underpaying for the Company. The transaction may undervalue the Company and would result in a loss for many long-term holders of Aratana stock. For example, Aratana stock has traded at $19.26 per share and an analyst has set a price target at $5.00 per share.

If you own shares of Aratana stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by visiting http://www.brodskysmith.com/cases/aratana-therapeutics-inc-nasdaq-petx/, or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE: Brodsky & Smith, LLC



View source version on accesswire.com:
https://www.accesswire.com/544362/SHAREHOLDER-UPDATE-Brodsky-Smith-LLC-Announces-an-Investigation-of-Aratana-Therapeutics-Inc-PETX